[Retracted] Knockdown of MALAT1 inhibits osteosarcoma progression via regulating the miR34a/cyclin D1 axis

Guangchao Duan1, Chuanlin Zhang1, Changke Xu1

  • 1Department of Spine Surgery, Shangqiu First People's Hospital, Shangqiu, Henan 476100, P.R. China.

Insights

This paper has been retracted due to concerns about duplicated data. Specifically, beta-actin control bands and assay data appeared in other publications before this submission.

Area of Science:

  • Oncology
  • Biochemistry

Background:

  • Concerns were raised regarding the duplication of scientific data.
  • Specific figures (Fig. 6D, 4D, 5E) showed data that had been previously submitted or published elsewhere.

Purpose of the Study:

  • To address concerns about data integrity and potential scientific misconduct.
  • To evaluate the validity of the published findings in light of duplicated data.

Main Methods:

  • Review of submitted figures and comparison with previously published data.
  • Investigation of data duplication across multiple figures and research articles.

Main Results:

  • Beta-actin control bands in Fig. 6D were found to have been submitted for publication previously.
  • Invasion assay data (Fig. 4D) and western blot data (Fig. 5E) were also identified in other publications.
  • Authors did not provide a response to the editorial office regarding these concerns.

Conclusions:

  • The paper is retracted from the International Journal of Oncology due to data duplication issues.
  • The integrity of the study's findings is compromised by the identified data reuse.
  • The editorial office apologizes for any inconvenience caused to the readership.